| Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018 | 191 | 2018 |
| Neuropharmacology of synthetic cathinones MH Baumann, HM Walters, M Niello, HH Sitte New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical …, 2018 | 99 | 2018 |
| Allosteric modulation of neurotransmitter transporters as a therapeutic strategy M Niello, R Gradisch, CJ Loland, T Stockner, HH Sitte Trends in pharmacological sciences 41 (7), 446-463, 2020 | 49 | 2020 |
| para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter M Niello, D Cintulova, E Hellsberg, K Jäntsch, M Holy, LH Ayatollahi, ... Neuropharmacology 161, 107615, 2019 | 30 | 2019 |
| Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones L Duart-Castells, N Nadal-Gratacós, M Muralter, B Puster, X Berzosa, ... Neuropharmacology 186, 108475, 2021 | 27 | 2021 |
| Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function S Bhat, M Niello, K Schicker, C Pifl, HH Sitte, M Freissmuth, W Sandtner Elife 10, e67996, 2021 | 23 | 2021 |
| α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: a pharmacological characterization of interactions between … J Maier, L Rauter, D Rudin, M Niello, M Holy, D Schmid, J Wilson, ... Neuropharmacology 190, 108570, 2021 | 21 | 2021 |
| The interaction of organic cation transporters 1-3 and PMAT with psychoactive substances J Maier, M Niello, D Rudin, LC Daws, HH Sitte Organic Cation Transporters in the Central Nervous System, 199-214, 2021 | 21 | 2021 |
| Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain R Gradisch, D Szöllősi, M Niello, E Lazzarin, HH Sitte, T Stockner Journal of Biological Chemistry 298 (3), 2022 | 17 | 2022 |
| A Novel and Selective Dopamine Transporter Inhibitor, (S)-MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions S Kouhnavardi, A Ecevitoglu, V Dragačević, F Sanna, E Arias-Sandoval, ... Biomolecules 12 (7), 881, 2022 | 15 | 2022 |
| Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro M Niello, D Cintulová, P Raithmayr, M Holy, K Jäntsch, C Colas, GF Ecker, ... Frontiers in pharmacology 12, 654061, 2021 | 14 | 2021 |
| Serotonin-releasing agents with reduced off-target effects FP Mayer, M Niello, D Cintulova, S Sideromenos, J Maier, Y Li, S Bulling, ... Molecular Psychiatry 28 (2), 722-732, 2023 | 13 | 2023 |
| Persistent binding at dopamine transporters determines sustained psychostimulant effects M Niello, S Sideromenos, R Gradisch, R O´ Shea, J Schwazer, J Maier, ... Proceedings of the National Academy of Sciences 120 (6), e2114204120, 2023 | 11* | 2023 |
| Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1–3 and Human Plasma Membrane Monoamine Transporter TJF Angenoorth, S Stankovic, M Niello, M Holy, SD Brandt, HH Sitte, ... International Journal of Molecular Sciences 22 (23), 12995, 2021 | 10 | 2021 |
| Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence U Sauerzopf, R Sacco, G Novarino, M Niello, A Weidenauer, ... European Journal of Neuroscience 45 (1), 45-57, 2017 | 5 | 2017 |
| Development and validation of an automated microfluidic perfusion platform for parallelized screening of compounds in vitro FR Brugnoli, M Holy, M Niello, J Maier, M Hanreich, M Menzel, ... Basic & Clinical Pharmacology & Toxicology 133 (5), 535-547, 2023 | 3 | 2023 |
| Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors R Gradisch, K Schlögl, E Lazzarin, M Niello, J Maier, FP Mayer, ... Nature Communications 15 (1), 417, 2024 | 2* | 2024 |
| The metabolic regulator USF-1 is involved in the control of affective behaviour in mice S Sideromenos, M Nikou, B Czuczu, N Thalheimer, A Gundacker, ... Translational Psychiatry 12 (1), 497, 2022 | 2 | 2022 |
| Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties P Puigseslloses, N Nadal-Gratacós, G Ketsela, N Weiss, X Berzosa, ... Molecular Psychiatry, 1-13, 2024 | | 2024 |
| Bioisosteric analogs of MDMA with improved pharmacological profile AS Alberto-Silva, S Hemmer, HA Bock, L Alves da Silva, KR Scott, ... bioRxiv, 2024.04. 08.588083, 2024 | | 2024 |
Harald H. SitteProfessor of Psychopharmacology, Medical University ViennaEmail verificata su meduniwien.ac.at
